Vascular Endothelial Growth Factors
"Vascular Endothelial Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.
| Descriptor ID |
D042442
|
| MeSH Number(s) |
D12.644.276.100.800 D12.776.467.100.800 D23.529.100.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vascular Endothelial Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Vascular Endothelial Growth Factors".
This graph shows the total number of publications written about "Vascular Endothelial Growth Factors" by people in this website by year, and whether "Vascular Endothelial Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vascular Endothelial Growth Factors" by people in Profiles.
-
Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome. J Infect Dis. 2021 09 17; 224(6):1101-1103.
-
Comment on: Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome. J Infect Dis. 2021 09 17; 224(6):1103-1104.
-
Comment on "Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak". ACS Chem Neurosci. 2021 07 21; 12(14):2712-2713.
-
Short term visual and structural outcomes of anti-vascular endothelial growth factor (anti-VEGF) treatment delay during the first COVID-19 wave: A pilot study. PLoS One. 2021; 16(2):e0247161.
-
VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes. Hypertension. 2018 04; 71(4):638-647.
-
Role of angiogenic factors in the pathogenesis and management of pre-eclampsia. Int J Gynaecol Obstet. 2018 Apr; 141(1):5-13.
-
Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study. BMC Cancer. 2017 Jun 15; 17(1):419.
-
Intravitreal Anti-Vascular Endothelial Growth Factor Drugs for Retinal Angiomatous Proliferation in Real-Life Practice. J Ocul Pharmacol Ther. 2017 03; 33(2):123-127.
-
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications. Leuk Lymphoma. 2017 07; 58(7):1711-1720.
-
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma. Cancer Chemother Pharmacol. 2014 Jul; 74(1):77-84.